Manulife (Manufacturers Life Insurance)
TPTX

Manulife (Manufacturers Life Insurance)’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-18,512
Closed -$1.39M – 3030
2022
Q2 		$1.39M Sell
18,512
-31,820
-63% -$1.41M ﹤0.01% 1512
2022
Q1 		$1.35M Buy
50,332
+26,787
+114% +$900K ﹤0.01% 1623
2021
Q4 		$1.14K Buy
23,545
+40
+0.2% +$1.79K ﹤0.01% 1753
2021
Q3 		$1.56M Sell
23,505
-2,223
-9% -$158K ﹤0.01% 1592
2021
Q2 		$2.01M Buy
25,728
+4,793
+23% +$354K ﹤0.01% 1606
2021
Q1 		$1.98M Sell
20,935
-1,212
-5% -$144K ﹤0.01% 1541
2020
Q4 		$2.7M Buy
22,147
+2,643
+14% +$290K ﹤0.01% 1431
2020
Q3 		$1.7M Buy
19,504
+2,803
+17% +$195K ﹤0.01% 1464
2020
Q2 		$1.07M Sell
16,701
-1,063
-6% -$61.3K ﹤0.01% 1585
2020
Q1 		$793K Buy
17,764
+13,097
+281% +$696K ﹤0.01% 1619
2019
Q4 		$291K Buy
+4,667
New +$222K ﹤0.01% 2360

Manulife (Manufacturers Life Insurance)'s TPTX Position: Q3 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 18,512 shares — an estimated $1.39M sold.

Manulife (Manufacturers Life Insurance) first reported a position in TPTX in Q4 2019 and held it in 11 quarters. The position peaked at $2.7M in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 18,512 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1.39M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
  • Manulife (Manufacturers Life Insurance)'s Turning Point Therapeutics, Inc. Common Stock position peaked at $2.7M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2022, filed 3 Nov 2022.